mitapivat
General
Pronunciation:
mye-ta-piv-at
Trade Name(s)
- Pyrukynd
Ther. Class.
Pharm. Class.
temporary class
pyruvate kinase activatorThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Mitapivat." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580066/4/mitapivat.
Vallerand AHA, Sanoski CAC. Mitapivat. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580066/4/mitapivat. Accessed June 25, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Mitapivat. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580066/4/mitapivat
Vallerand AHA, Sanoski CAC. Mitapivat [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 25]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580066/4/mitapivat.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - mitapivat
ID - 3580066
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/3580066/4/mitapivat
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

